The FDA has approved suzetrigine, a groundbreaking painkiller that blocks sodium channels to provide opioid-level pain relief without the risks of addiction, sedation, or overdose. Known as Journavx, this drug is the first in over two decades to introduce a new pain relief mechanism. Clinical trials showed it matched opioids in effectiveness but with fewer side effect…
Related Posts
Naughty Dog May Not Work on The Last of Us Part 3, Neil Druckmann Suggests
- staff
- March 6, 2025
- 0
The Last of Us Part 2 might not get a sequel, Naughty Dog president Neil Druckmann has suggested. According to him, there might not be […]
Mario Kart World, Donkey Kong Bananza, The Duskbloods: Every Game Coming to Nintendo Switch 2
- staff
- April 3, 2025
- 0
Nintendo fully unveiled its next-generation hybrid console in a Nintendo Direct presentation Wednesday, finally giving the world a closer look at the Switch 2. In […]
Asus Vivobook 14 Flip (2025) Review: A Versatile 2-in-1 Laptop
- staff
- February 24, 2025
- 0
The Asus Vivobook 14 Flip has a premium and sleek design language. The laptop packs a 14-inch Full HD+ OLED display that offers decent colours. […]